S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Buy THIS stock before Taiwan is attacked (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Stocks are for suckers – try this instead (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Stocks are for suckers – try this instead (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Buy THIS stock before Taiwan is attacked (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Stocks are for suckers – try this instead (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Stocks are for suckers – try this instead (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Buy THIS stock before Taiwan is attacked (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Stocks are for suckers – try this instead (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Stocks are for suckers – try this instead (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Buy THIS stock before Taiwan is attacked (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Stocks are for suckers – try this instead (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Stocks are for suckers – try this instead (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
TSE:VBV

VBI Vaccines - VBV Stock Forecast, Price & News

Add
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1,300 shs
Average Volume
3,637 shs
Market Capitalization
C$308.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VBV stock logo

About VBI Vaccines (TSE:VBV) Stock

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.

Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

VBV Stock News Headlines

March 30, 2023 | nypost.com
How mRNA vaccines could target everything from cancer to the plague
March 28, 2023 | nbcnews.com
Moderna CEO grilled over plan to raise Covid vaccine price at Senate hearing
April 1, 2023 | Vantage Point (Ad)
What’s At Stake In April is Shocking
The Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. pixel
March 15, 2023 | usatoday.com
People without insurance will still get free COVID vaccines once government's supply runs out
March 13, 2023 | foxnews.com
LA County eases COVID vaccine, testing restrictions as emergency declarations end
February 24, 2023 | cnbc.com
Flu vaccine was 68% effective at preventing hospitalization in children but less protective for seniors this season
February 22, 2023 | reuters.com
Develop vaccines for all animal influenza strain, says incoming WHO chief scientist
February 22, 2023 | foxnews.com
Prior COVID infection provides just as much protection as vaccines, new study finds
April 1, 2023 | Vantage Point (Ad)
What’s At Stake In April is Shocking
The Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. pixel
February 20, 2023 | usnews.com
Two Vaccines May Soon Shield Seniors Against RSV
February 15, 2023 | marketwatch.com
The Rise of Virus-like Particles (VLPs) Vaccine Market Research 2023-2029: Opportunities and Challenges
February 11, 2023 | finance.yahoo.com
Advances and Growth Opportunities in RNA Vaccines
February 9, 2023 | usatoday.com
FDA vaccine panel to consider annual COVID shots: What we know
January 26, 2023 | foxnews.com
Yearly COVID vaccine as proposed by FDA? 'Cart before the horse,' says doctor
January 25, 2023 | abcnews.go.com
FDA proposes most Americans receive one annual COVID vaccine, similar to flu
January 25, 2023 | reuters.com
U.S. FDA proposes shift to annual COVID vaccine shots
January 24, 2023 | cnet.com
Scientists Are Working on a COVID Vaccine You Can Drink
January 22, 2023 | cnbc.com
RSV vaccine: Moderna, Pfizer start a new FDA approval race
January 16, 2023 | nypost.com
CDC investigating whether Pfizer COVID vaccine increases stroke risk for people over 65
January 14, 2023 | marketwatch.com
Vaccine Market Latest Trends 2023, Drivers, and Projections Report from 2023-2029| 101 Pages Report
January 14, 2023 | nypost.com
Moderna under fire for 400% price hike of COVID vaccine: ‘Outrageous’
January 13, 2023 | nypost.com
Pentagon ends COVID-19 vaccine mandate for US troops
January 10, 2023 | marketwatch.com
VLP Vaccines Market Global and Regional Analysis and Forecast 2028
December 20, 2022 | msn.com
Looking Into VBI Vaccines's Return On Capital Employed
November 10, 2022 | marketwatch.com
VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update
October 15, 2022 | finance.yahoo.com
FDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of Age
September 15, 2022 | finance.yahoo.com
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
See More Headlines
Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
N/A
Sub-Industry
N/A
Sector
N/A
Current Symbol
TSE:VBV
CUSIP
N/A
CIK
N/A
Web
www.vbivaccines.com
Phone
+1-617-8303031
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
14.29
Current Ratio
2.64
Quick Ratio
2.54

Sales & Book Value

Annual Sales
C$3.36 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
C$1.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
64,079,000
Free Float
N/A
Market Cap
C$308.86 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jeff R. Baxter (Age 57)
    CEO, Pres & Director
  • Dr. David Evander Anderson Ph.D. (Age 48)
    Chief Scientific Officer
  • Ms. Athena Kartsaklis (Age 53)
    Sr. VP of Fin., Principal Financial & Accounting Officer, Chief Compliance Officer
  • Ms. Nell Beattie (Age 30)
    Chief Bus. Officer
  • Dr. Francisco Diaz-Mitoma M.D. (Age 63)
    Ph.D., Chief Medical Officer













VBV Stock - Frequently Asked Questions

What other stocks do shareholders of VBI Vaccines own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VBI Vaccines investors own include Teladoc Health (TDOC), PhaseBio Pharmaceuticals (PHAS), Amarin (AMRN), Adverum Biotechnologies (ADVM), Assertio (ASRT), Activision Blizzard (ATVI), Axsome Therapeutics (AXSM), Boeing (BA), Beyond Meat (BYND) and Cardlytics (CDLX).

What is VBI Vaccines' stock symbol?

VBI Vaccines trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VBV."

How do I buy shares of VBI Vaccines?

Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does VBI Vaccines make?

VBI Vaccines (TSE:VBV) has a market capitalization of C$0.00 and generates C$3.36 million in revenue each year.

How can I contact VBI Vaccines?

VBI Vaccines' mailing address is 222 3rd St Ste 2241, CAMBRIDGE, MA 02142-1259, United States. The official website for the company is www.vbivaccines.com. The company can be reached via phone at +1-617-8303031.

This page (TSE:VBV) was last updated on 4/1/2023 by MarketBeat.com Staff